Literature DB >> 19765672

Diseases and drugs that increase risk of acute large bowel ischemia.

George F Longstreth1, Janis F Yao.   

Abstract

BACKGROUND & AIMS: Information is limited on risk factors for acute large bowel ischemia (ALBI). We investigated diseases and drugs associated with ALBI.
METHODS: We compared patients hospitalized with ALBI and controls through multivariate analysis of prior outpatient/emergency department/inpatient diagnoses and pharmacy dispensing records.
RESULTS: There were 379 cases and 1516 controls (median age, 69 y; range, 25-97 y; 74.4% female). Disorders that were diagnosed in more cases than controls, based on univariate analysis (P < .05), included hypertension, diabetes, chronic obstructive pulmonary disease, atrial fibrillation, congestive heart failure, depression, asthma, coronary artery disease, dementia, rheumatoid arthritis, irritable bowel syndrome, dialysis dependency, diarrhea, and constipation. Drugs dispensed to more cases than controls were antihypertensives, opioids, statins, female hormones, potentially constipating drugs, histamine H(2)-antagonists, immunomodulators, digoxin, clopidogrel/ticlopidine, taxanes/vinca alkaloids, and antibiotics. In all cases, ALBI was associated independently with hypertension (adjusted odds ratio [AOR], 3.21, 95% confidence interval [CI]; 2.28-4.53; P < .0001), chronic obstructive pulmonary disease (AOR, 3.13; 95% CI, 2.06-4.75; P < .0001), diarrhea (AOR, 2.36; 95% CI, 1.13-4.89; P = .0218), atrial fibrillation (AOR, 2.21; 95% CI, 1.34-3.64; P = .0019), congestive heart failure (AOR, 1.94; 95% CI, 1.11-3.39; P = .0205), diabetes (AOR, 1.82; 95% CI, 1.31-2.53; P = .0004), antibiotics (AOR, 3.30; 95% CI, 2.19-4.96; P < .0001), opioids (AOR, 1.96; 95% CI, 1.43-2.67; P < .0001), and potentially constipating drugs (AOR, 1.75; 95% CI, 1.25-2.44; P = .0012). Analysis of only women revealed similar associations except for diarrhea plus rheumatoid arthritis (AOR, 3.27; 95% CI, 1.07-9.96; P = .0370), irritable bowel syndrome (AOR, 2.72; 95% CI, 1.04-7.14; P = .0424), and female hormones (AOR, 1.88; 95% CI, 1.30-2.73; P = .0009).
CONCLUSIONS: Heterogeneous diseases and drugs increase the risk of ALBI, consistent with multifactorial pathogenesis. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19765672     DOI: 10.1016/j.cgh.2009.09.006

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  16 in total

1.  Irritable bowel syndrome and ischemic colitis: evidence supporting the increased use of alosetron.

Authors:  Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  Abdominal Fat Accumulation, as Measured by Computed Tomography, Increases the Risk of Ischemic Colitis: A Retrospective Case-Control Study.

Authors:  Tomonori Aoki; Naoyoshi Nagata; Kayo Sakamoto; Tomohiro Arai; Ryota Niikura; Takuro Shimbo; Masafumi Shinozaki; Katsunori Sekine; Hidetaka Okubo; Kazuhiro Watanabe; Toshiyuki Sakurai; Chizu Yokoi; Junichi Akiyama; Mikio Yanase; Masashi Mizokami; Mitsuhiko Noda; Naomi Uemura
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

3.  ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI).

Authors:  Lawrence J Brandt; Paul Feuerstadt; George F Longstreth; Scott J Boley
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

Review 4.  Ischaemic colitis: practical challenges and evidence-based recommendations for management.

Authors:  Alex Hung; Tom Calderbank; Mark A Samaan; Andrew A Plumb; George Webster
Journal:  Frontline Gastroenterol       Date:  2019-12-13

5.  Ischaemic colitis associated with oral contraceptive and bisacodyl use.

Authors:  Shahnaz Ajani; Ryan T Hurt; David A Teeters; Lawrence R Bellmore
Journal:  BMJ Case Rep       Date:  2012-07-25

Review 6.  Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERS.

Authors:  Thuc Quyen Nguyen; James H Lewis
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

Review 7.  Rizatriptan-Induced Colonic Ischemia: A Case Report and Literature Review.

Authors:  Thomas D Dieringer; David M Crossland; Thomas C Mahl
Journal:  Am J Gastroenterol       Date:  2018-01       Impact factor: 10.864

Review 8.  The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.

Authors:  James H Lewis
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

9.  Natural history of outpatient-onset ischemic colitis compared with other lower gastrointestinal bleeding: a long-term cohort study.

Authors:  Naoyoshi Nagata; Ryota Niikura; Tomonori Aoki; Takuro Shimbo; Yoshihiro Kishida; Katsunori Sekine; Shohei Tanaka; Hidetaka Okubo; Kazuhiro Watanabe; Toshiyuki Sakurai; Chizu Yokoi; Junichi Akiyama; Mikio Yanase; Masashi Mizokami; Naomi Uemura
Journal:  Int J Colorectal Dis       Date:  2014-11-30       Impact factor: 2.571

10.  Right-Side Colon Ischemia: Clinical Features, Large Visceral Artery Occlusion, and Long-Term Follow-Up.

Authors:  George F Longstreth; Robert J Hye
Journal:  Perm J       Date:  2015-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.